Congenital Hematological Disorder Completed Phase Trials for Coagulation factor VII human (DB13150)

Back to Congenital Hematological Disorder

Also known as: Congenital bleeding disorders / Congenital Bleeding Disorder / Congenital haematological disorder

IndicationStatusPhase
DBCOND0081791 (Congenital Hematological Disorder)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01876745A Study to Evaluate Safety and Efficacy of NovoSeven® in Patients With Glanzmann's Thrombasthenia in Japan
NCT01779921Treatment of Congenital Factor VII Deficiency
NCT01476423Observational Registry of the Treatment of Glanzmann's Thrombasthenia
NCT01312636Observational Study on Safety and Efficacy of NovoSeven® in Subjects With Congenital FVII Deficiency
NCT01234545Observational Study Describing the Usual Clinical Practice Use of NovoSeven® in the Home Treatment of Joint Bleeds in Patients With Haemophilia A or B and Inhibitors
NCT01220141Observational Study on Safety of Room Temperature Stable NovoSeven® in Patients With Haemophilia A or B
NCT00882778PROPACT: Retrospective Prophylaxis Patient Case Collection
NCT00853086Post-marketing Safety Surveillance of NovoSeven® in Patients With Haemophilia and Inhibitors by Means of the UK Haemophilia Database
NCT00710619Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX
NCT00703911Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors
NCT00697320Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany